Clinical trials

AIDS 2008: Is the HIV drug pipeline drying up?

The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-resistant HIV, all of which are now available in Australia.

People with HIV need informed, independent advice to make treatment decisions

Continuing improvements in HIV treatment are helping many people with HIV lead healthy lives, but some HIV-positive people may not be well-enough informed about the latest treatment options, the National Association of People Living with HIV/AIDS (NAPWA) has said in a statement to mark the launch of an innovative new HIV treatments information project.

IAS 2007: Promising signs

A major HIV/AIDS medical conference in Sydney has generated lots of news on the treatments front, reports Paul Kidd.

Backgrounder: HIV basics

Oranges and lemons: understanding clinical trials

We devote a fair amount of space in Positive Living to reporting the results of clinical trials, but do you understand why medical research is done this way? This Backgrounder looks at the science behind clinical trials.

Stepping up to the plate

Volunteers are now being sought for the clinical trial of an experimental preventive HIV vaccine. People at high risk of contracting HIV, aged between 18 and 45, who live in Sydney are eligible for the trial.

Viral rebound: How stop-start spelled the end for SMART

The sudden cancellation of a large HIV clinical study has significant implications for how we treat HIV. KIRSTY MACHON reports.

Rocky Mountain CROI

 The 13th annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the SMART study, but as usual, this important conference produced a great deal more than a single story.

The art of being naive

There are numerous issues to be considered before going on a clinical trial, writes PETER WATTS.

Facing trial at last

p(standfirst).  It’s been three years in the making, but an Australian trial of polylactic acid for the treatment of facial wasting is about to get underway at last. But while the news is good, there are some important limitations to this project. KIRSTY MACHON reports.

A tale of two cities

With major medical conferences in the United States and Scotland, November was a busy month for HIV medicine. PAUL KIDD reviews some key findings.